Mankind Pharma information

Mankind Pharma
Company type	Public
Traded as	NSE: MANKIND; BSE: 543904;
ISIN	INE634S01028
Industry	Pharmaceutical
Founded	1991; 33 years ago
Founders	Ramesh C. Juneja; Rajeev Juneja;
Headquarters	Okhla Phase III, Delhi, India
Area served	Worldwide
Key people	Ramesh Juneja (Chairman); Rajeev Juneja (MD & Vice Chairman); Sheetal Arora (CEO); Arjun Juneja (COO);
Products	Pharmaceuticals; Generic drugs; OTC; FMCG; Diagnostics;
Revenue	₹8,749 crore (US$1.1 billion) (FY23)
Operating income	₹1,913 crore (US$240 million) (FY23)
Net income	₹1,310 crore (US$160 million) (FY23)
Number of employees	22,000+ (2023)
Website	www.mankindpharma.com

Mankind Pharma is an Indian pharmaceutical and healthcare products company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.^[5]^[6]^[7]

As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India.^[8] The company derived 97% of its operating revenue from the Indian market,^[9] where it is reportedly the fourth largest pharmaceutical company by domestic sales.^[8] Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms,^[10] Prega News in pregnancy test kits,^[11] and Unwanted-72 in emergency contraception.^[12]

^ Bhalla, Mohit; Rajagopal, Divya. "Mankind Pharma: The story of Juneja siblings, the biggest disruptors in Indian pharma space". The Economic Times. Retrieved 21 December 2022.
^ Singh, Khomba. "Mankind Pharma's pocket-friendly pricing in demand". The Economic Times. Retrieved 21 December 2022.
^ ^a ^b ^c Das, Vipul (30 May 2023). "Mankind Pharma Q4 results: PAT zooms 52% YoY to ₹294 Cr, revenue up 19%". mint. Retrieved 31 May 2023.
^ "Mankind Pharma Forays Into Critical Care Segment". Outlook India. Retrieved 12 April 2023.
^ "India's Mankind Pharma wants deals, sees FY domestic sales topping $700 mln". Reuters. 10 April 2015. Retrieved 21 March 2023.
^ Raturi, Prerna (11 February 2012). "For a robust business". Business Standard. Archived from the original on 27 April 2012. Retrieved 7 May 2023.
^ Singh, Raveena (20 March 2023). "At $6-7B, Mankind Pharma eyes Torrent's valuation. But its catch lies in Eris & Gland IPOs". The Ken. Retrieved 21 March 2023.
^ ^a ^b Raghunathan, Anu (11 October 2023). "Mankind Pharma's Founders Map Growth Plan After Pulling Off Major IPO". Forbes. Retrieved 4 December 2023.
^ "India's biggest condom maker lifts dreary IPO market". Financial Times. 27 April 2023. Retrieved 4 December 2023.
^ Tandon, Suneera (18 February 2022). "Durex becomes second-largest condom brand in India: Reckitt". Mint. Retrieved 22 November 2022.
^ "Behind Mankind's plans to take Prega News to rural markets". Moneycontrol. Retrieved 22 November 2022.
^ "Mankind Pharma Ltd" (PDF). Geojit. Retrieved 24 April 2023.

[1] Bhalla, Mohit; Rajagopal, Divya. "Mankind Pharma: The story of Juneja siblings, the biggest disruptors in Indian pharma space". The Economic Times. Retrieved 21 December 2022.

[2] Singh, Khomba. "Mankind Pharma's pocket-friendly pricing in demand". The Economic Times. Retrieved 21 December 2022.

[fy23-3] Das, Vipul (30 May 2023). "Mankind Pharma Q4 results: PAT zooms 52% YoY to ₹294 Cr, revenue up 19%". mint. Retrieved 31 May 2023.

[4] "Mankind Pharma Forays Into Critical Care Segment". Outlook India. Retrieved 12 April 2023.

[5] "India's Mankind Pharma wants deals, sees FY domestic sales topping $700 mln". Reuters. 10 April 2015. Retrieved 21 March 2023.

[6] Raturi, Prerna (11 February 2012). "For a robust business". Business Standard. Archived from the original on 27 April 2012. Retrieved 7 May 2023.

[7] Singh, Raveena (20 March 2023). "At $6-7B, Mankind Pharma eyes Torrent's valuation. But its catch lies in Eris & Gland IPOs". The Ken. Retrieved 21 March 2023.

[forbes-8] Raghunathan, Anu (11 October 2023). "Mankind Pharma's Founders Map Growth Plan After Pulling Off Major IPO". Forbes. Retrieved 4 December 2023.

[9] "India's biggest condom maker lifts dreary IPO market". Financial Times. 27 April 2023. Retrieved 4 December 2023.

[10] Tandon, Suneera (18 February 2022). "Durex becomes second-largest condom brand in India: Reckitt". Mint. Retrieved 22 November 2022.

[11] "Behind Mankind's plans to take Prega News to rural markets". Moneycontrol. Retrieved 22 November 2022.

[12] "Mankind Pharma Ltd" (PDF). Geojit. Retrieved 24 April 2023.

Mankind Pharma information

and 25 Related for: Mankind Pharma information

Mankind Pharma

Ramesh Juneja

Pathkind Labs

Intas Pharmaceuticals

Paonta Sahib

Pharmaceutical industry in India

Terbinafine

List of companies based in Gurgaon

Manesar

Dydrogesterone

Sonu Nigam discography

NIFTY 500

Illuminati

Molnupiravir

Philanthropy

Nibiru cataclysm

Res ipsa loquitur

Welch Award in Chemistry

Phrenology

Anthony Fauci

Confirmation bias

Emerging technologies

2012 phenomenon

Bill Gates

List of Linux games